Logo image of MTX

MINERALS TECHNOLOGIES INC (MTX) Stock Fundamental Analysis

USA - NYSE:MTX - US6031581068 - Common Stock

64.83 USD
+1.62 (+2.56%)
Last: 9/17/2025, 1:35:17 PM
Fundamental Rating

4

Taking everything into account, MTX scores 4 out of 10 in our fundamental rating. MTX was compared to 83 industry peers in the Chemicals industry. MTX has an average financial health and profitability rating. MTX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

MTX had positive earnings in the past year.
In the past year MTX had a positive cash flow from operations.
In the past 5 years MTX has always been profitable.
In the past 5 years MTX always reported a positive cash flow from operatings.
MTX Yearly Net Income VS EBIT VS OCF VS FCFMTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

MTX has a Return On Assets of 0.06%. This is comparable to the rest of the industry: MTX outperforms 49.40% of its industry peers.
MTX's Return On Equity of 0.13% is in line compared to the rest of the industry. MTX outperforms 50.60% of its industry peers.
MTX has a worse Return On Invested Capital (2.13%) than 65.06% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MTX is in line with the industry average of 6.34%.
The 3 year average ROIC (6.89%) for MTX is well above the current ROIC(2.13%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.06%
ROE 0.13%
ROIC 2.13%
ROA(3y)3.68%
ROA(5y)3.88%
ROE(3y)7.46%
ROE(5y)8.15%
ROIC(3y)6.89%
ROIC(5y)6.42%
MTX Yearly ROA, ROE, ROICMTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 0.10%, MTX is in line with its industry, outperforming 49.40% of the companies in the same industry.
MTX's Profit Margin has been stable in the last couple of years.
With a Operating Margin value of 3.91%, MTX is not doing good in the industry: 66.27% of the companies in the same industry are doing better.
MTX's Operating Margin has been stable in the last couple of years.
MTX has a Gross Margin (25.41%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of MTX has remained more or less at the same level.
Industry RankSector Rank
OM 3.91%
PM (TTM) 0.1%
GM 25.41%
OM growth 3Y1.32%
OM growth 5Y0.73%
PM growth 3Y-3.75%
PM growth 5Y1.26%
GM growth 3Y2.47%
GM growth 5Y1%
MTX Yearly Profit, Operating, Gross MarginsMTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

5

2. Health

2.1 Basic Checks

MTX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
MTX has less shares outstanding than it did 1 year ago.
MTX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, MTX has an improved debt to assets ratio.
MTX Yearly Shares OutstandingMTX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MTX Yearly Total Debt VS Total AssetsMTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 2.51 indicates that MTX is not a great score, but indicates only limited risk for bankruptcy at the moment.
MTX has a better Altman-Z score (2.51) than 72.29% of its industry peers.
MTX has a debt to FCF ratio of 11.09. This is a negative value and a sign of low solvency as MTX would need 11.09 years to pay back of all of its debts.
MTX has a better Debt to FCF ratio (11.09) than 61.45% of its industry peers.
A Debt/Equity ratio of 0.59 indicates that MTX is somewhat dependend on debt financing.
The Debt to Equity ratio of MTX (0.59) is better than 63.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 11.09
Altman-Z 2.51
ROIC/WACC0.24
WACC8.8%
MTX Yearly LT Debt VS Equity VS FCFMTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

MTX has a Current Ratio of 1.95. This is a normal value and indicates that MTX is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.95, MTX perfoms like the industry average, outperforming 46.99% of the companies in the same industry.
MTX has a Quick Ratio of 1.35. This is a normal value and indicates that MTX is financially healthy and should not expect problems in meeting its short term obligations.
MTX has a Quick ratio of 1.35. This is comparable to the rest of the industry: MTX outperforms 55.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.35
MTX Yearly Current Assets VS Current LiabilitesMTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2

3. Growth

3.1 Past

The earnings per share for MTX have decreased by -3.55% in the last year.
Measured over the past 5 years, MTX shows a small growth in Earnings Per Share. The EPS has been growing by 7.77% on average per year.
MTX shows a decrease in Revenue. In the last year, the revenue decreased by -3.93%.
The Revenue has been growing slightly by 3.42% on average over the past years.
EPS 1Y (TTM)-3.55%
EPS 3Y7.07%
EPS 5Y7.77%
EPS Q2Q%-6.06%
Revenue 1Y (TTM)-3.93%
Revenue growth 3Y4.47%
Revenue growth 5Y3.42%
Sales Q2Q%-2.27%

3.2 Future

The Earnings Per Share is expected to grow by 2.33% on average over the next years.
Based on estimates for the next years, MTX will show a small growth in Revenue. The Revenue will grow by 1.09% on average per year.
EPS Next Y-9.51%
EPS Next 2Y2.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.24%
Revenue Next 2Y1.09%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MTX Yearly Revenue VS EstimatesMTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
MTX Yearly EPS VS EstimatesMTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.37, the valuation of MTX can be described as reasonable.
83.13% of the companies in the same industry are more expensive than MTX, based on the Price/Earnings ratio.
MTX is valuated cheaply when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
MTX is valuated reasonably with a Price/Forward Earnings ratio of 10.07.
Based on the Price/Forward Earnings ratio, MTX is valued cheaper than 86.75% of the companies in the same industry.
MTX is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.71, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.37
Fwd PE 10.07
MTX Price Earnings VS Forward Price EarningsMTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

MTX's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, MTX is valued a bit cheaper than the industry average as 65.06% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 22.94
EV/EBITDA 15.12
MTX Per share dataMTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.46
EPS Next 2Y2.33%
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.68%, MTX is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.43, MTX is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.38, MTX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.68%

5.2 History

On average, the dividend of MTX grows each year by 15.37%, which is quite nice.
MTX has paid a dividend for at least 10 years, which is a reliable track record.
MTX has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)15.37%
Div Incr Years2
Div Non Decr Years31
MTX Yearly Dividends per shareMTX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

MTX pays out 652.38% of its income as dividend. This is not a sustainable payout ratio.
MTX's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP652.38%
EPS Next 2Y2.33%
EPS Next 3YN/A
MTX Yearly Income VS Free CF VS DividendMTX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M
MTX Dividend Payout.MTX Dividend Payout, showing the Payout Ratio.MTX Dividend Payout.PayoutRetained Earnings

MINERALS TECHNOLOGIES INC

NYSE:MTX (9/17/2025, 1:35:17 PM)

64.83

+1.62 (+2.56%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)10-22 2025-10-22/amc
Inst Owners100.99%
Inst Owner Change1.59%
Ins Owners1.16%
Ins Owner Change0.37%
Market Cap2.03B
Analysts80
Price Target85.68 (32.16%)
Short Float %1.6%
Short Ratio1.93
Dividend
Industry RankSector Rank
Dividend Yield 0.68%
Yearly Dividend0.41
Dividend Growth(5Y)15.37%
DP652.38%
Div Incr Years2
Div Non Decr Years31
Ex-Date08-15 2025-08-15 (0.11)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.17%
Min EPS beat(2)-4.75%
Max EPS beat(2)9.1%
EPS beat(4)2
Avg EPS beat(4)2.67%
Min EPS beat(4)-4.75%
Max EPS beat(4)9.1%
EPS beat(8)6
Avg EPS beat(8)5.18%
EPS beat(12)8
Avg EPS beat(12)0.33%
EPS beat(16)12
Avg EPS beat(16)1.19%
Revenue beat(2)0
Avg Revenue beat(2)-1.11%
Min Revenue beat(2)-1.18%
Max Revenue beat(2)-1.03%
Revenue beat(4)0
Avg Revenue beat(4)-1.81%
Min Revenue beat(4)-3.09%
Max Revenue beat(4)-1.03%
Revenue beat(8)1
Avg Revenue beat(8)-1.64%
Revenue beat(12)3
Avg Revenue beat(12)-1.38%
Revenue beat(16)5
Avg Revenue beat(16)-1.13%
PT rev (1m)0%
PT rev (3m)3.38%
EPS NQ rev (1m)0.45%
EPS NQ rev (3m)-5.54%
EPS NY rev (1m)-1.67%
EPS NY rev (3m)-4.42%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.82%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-0.99%
Valuation
Industry RankSector Rank
PE 11.37
Fwd PE 10.07
P/S 0.99
P/FCF 22.94
P/OCF 10.77
P/B 1.23
P/tB 3.88
EV/EBITDA 15.12
EPS(TTM)5.7
EY8.79%
EPS(NY)6.44
Fwd EY9.93%
FCF(TTM)2.83
FCFY4.36%
OCF(TTM)6.02
OCFY9.29%
SpS65.76
BVpS52.71
TBVpS16.69
PEG (NY)N/A
PEG (5Y)1.46
Profitability
Industry RankSector Rank
ROA 0.06%
ROE 0.13%
ROCE 2.83%
ROIC 2.13%
ROICexc 2.39%
ROICexgc 4.3%
OM 3.91%
PM (TTM) 0.1%
GM 25.41%
FCFM 4.3%
ROA(3y)3.68%
ROA(5y)3.88%
ROE(3y)7.46%
ROE(5y)8.15%
ROIC(3y)6.89%
ROIC(5y)6.42%
ROICexc(3y)7.67%
ROICexc(5y)7.18%
ROICexgc(3y)13.35%
ROICexgc(5y)12.39%
ROCE(3y)9.31%
ROCE(5y)8.65%
ROICexcg growth 3Y6.72%
ROICexcg growth 5Y4.56%
ROICexc growth 3Y6.7%
ROICexc growth 5Y3.44%
OM growth 3Y1.32%
OM growth 5Y0.73%
PM growth 3Y-3.75%
PM growth 5Y1.26%
GM growth 3Y2.47%
GM growth 5Y1%
F-Score5
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 11.09
Debt/EBITDA 5.63
Cap/Depr 107.86%
Cap/Sales 4.86%
Interest Coverage 1.38
Cash Conversion 108.88%
Profit Quality 4223.81%
Current Ratio 1.95
Quick Ratio 1.35
Altman-Z 2.51
F-Score5
WACC8.8%
ROIC/WACC0.24
Cap/Depr(3y)93.37%
Cap/Depr(5y)131.49%
Cap/Sales(3y)4.14%
Cap/Sales(5y)6.45%
Profit Quality(3y)91.22%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.55%
EPS 3Y7.07%
EPS 5Y7.77%
EPS Q2Q%-6.06%
EPS Next Y-9.51%
EPS Next 2Y2.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.93%
Revenue growth 3Y4.47%
Revenue growth 5Y3.42%
Sales Q2Q%-2.27%
Revenue Next Year-2.24%
Revenue Next 2Y1.09%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-71.04%
EBIT growth 3Y5.84%
EBIT growth 5Y4.17%
EBIT Next Year19.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.25%
FCF growth 3YN/A
FCF growth 5Y-3.25%
OCF growth 1Y24.52%
OCF growth 3Y0.57%
OCF growth 5Y-0.16%